Equities
Health CareHealth Care Equipment & Services
  • Price (GBX)266.80
  • Today's Change-3.80 / -1.40%
  • Shares traded269.53k
  • 1 Year change-13.80%
  • Beta1.3269
Data delayed at least 20 minutes, as of Aug 14 2020 16:00 BST.
More ▼

Key statistics

As of last trade, Mediclinic International PLC (MDC:LSE) traded at 266.80, 14.80% above the 52 week low of 232.40 set on Apr 24, 2020.
52-week range
Today
232.40Apr 24 2020419.40Dec 16 2019
Markit short selling activity
Low
Med
High
Open270.00
High270.00
Low261.20
Bid266.40
Offer266.80
Previous close270.60
Average volume409.71k
Shares outstanding737.24m
Free float336.67m
P/E (TTM)--
Market cap1.99bn GBP
EPS (TTM)-0.4341
GBP
Annual div (ADY)--
Annual div yield (ADY)--
Div ex-dateDec 05 2019
Div pay-dateDec 17 2019
Data delayed at least 20 minutes, as of Aug 14 2020 16:00 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Mediclinic International PLC shares was Hold at 277.00 on 02 Jun 2020Read the full article
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.